N-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-κB-dependent mechanisms

Journal of Nutritional Biochemistry

Volumn 23, Issue 12, 2012, Pages 1661-1667

  Siriwardhana, Nalin ^a   Kalupahana, Nishan S ^a   Fletcher, Sarah ^a,b   Xin, Wenting ^a   Claycombe, Kate J ^c   Quignard Boulange, Annie ^d   Zhao, Ling ^a   Saxton, Arnold M ^a,b   Moustaid Moussa, Naima ^a,b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Genome Science and Technology Program   (United States)

^c GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^d AGROPARISTECH   (France)

Author keywords

Adipocyte; Agt; Arachidonic acid; Eicosapentaenoic acid; IL 6; Inflammation; MCP 1; PUFA

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; ADIPOCYTOKINE; ANGIOTENSINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; VITRONECTIN;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; DRUG MECHANISM; EPIDIDYMIS FAT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANGIOTENSINOGEN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; CELL DIFFERENTIATION; CHEMOKINE CCL2; DIET, HIGH-FAT; EICOSAPENTAENOIC ACID; INFLAMMATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B;

EID: 84869083260     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.11.009     Document Type: Article

References (49)

1. Finkelstein E.A., Trogdon J.G., Cohen J.W., Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff 2009, 28:W822-W831.
2. Tsai A.G., Williamson D.F., Glick H.A. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev 2011, 12:50-61.
3. Perez Perez A., Ybarra Munoz J., Blay Cortes V., de Pablos Velasco P. Obesity and cardiovascular disease. Public Health Nutr 2007, 10:1156-1163.
4. Poirier P., Eckel R.H. Obesity and cardiovascular disease. Curr Atheroscler Rep 2002, 4:448-453.
5. Teixeira P.J., Sardinha L.B., Going S.B., Lohman T.G. Total and regional fat and serum cardiovascular disease risk factors in lean and obese children and adolescents. Obes Res 2001, 9:432-442.
6. Yvan-Charvet L., Quignard-Boulange A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 2011, 79:162-168.
7. Franks P.W. Obesity, inflammatory markers and cardiovascular disease: distinguishing causality from confounding. J Hum Hypertens 2006, 20:837-840.
8. Dandona P., Aljada A., Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004, 25:4-7.
9. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010, 1212:E1-E19.
10. Lee M.J., Wu Y., Fried S.K. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care 2010, 13:371-376.
11. Kalupahana N.S., Moustaid-Moussa N., Claycombe K.J. Immunity as a link between obesity and insulin resistance. Mol Aspects Med 2012, 33:26-34.
12. Massiera F., Bloch-Faure M., Ceiler D., Murakami K., Fukamizu A., Gasc J.M., et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001, 15:2727-2729.
13. Van Harmelen V., Ariapart P., Hoffstedt J., Lundkvist I., Bringman S., Arner P. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 2000, 8:337-341.
14. Kalupahana N.S., Massiera F., Quignard-Boulange A., Ailhaud G., Voy B.H., Wasserman D., et al. Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance and insulin resistance. Obesity 2012, 20:48-56.
15. Lee M.H., Song H.K., Ko G.J., Kang Y.S., Han S.Y., Han K.H., et al. Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int 2008, 74:890-900.
16. Jayasooriya A.P., Mathai M.L., Walker L.L., Begg D.P., Denton D.A., Cameron-Smith D., et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci U S A. 2008, 105:6531-6536.
17. Kalupahana N.S., Moustaid-Moussa N. The renin-angiotensin system: a link between obesity and insulin resistance. Obes Rev 2012, 13:136-149.
18. Yvan-Charvet L., Even P., Bloch-Faure M., Guerre-Millo M., Moustaid-Moussa N., Ferre P., et al. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 2005, 54:991-999.
19. Kim S., Urs S., Massiera F., Wortmann P., Joshi R., Heo Y.R., et al. Effects of high-fat diet, angiotensinogen (agt) gene inactivation, and targeted expression to adipose tissue on lipid metabolism and renal gene expression. Horm Metab Res 2002, 34:721-725.
20. Yvan-Charvet L., Massiéra F., Lamandé N., Ailhaud G., Teboul M., Moustaid-Moussa N., et al. Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue. Endocrinology 2009, 150:1421-1428.
21. Jones B.H., Standridge M.K., Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997, 138:1512-1519.
22. Kim S., Dugail I., Standridge M., Claycombe K., Chun J., Moustaid-Moussa N. Angiotensin II-responsive element is the insulin-responsive element in the adipocyte fatty acid synthase gene: role of adipocyte determination and differentiation factor 1/sterol-regulatory-element-binding protein 1c. Biochem J 2001, 357:899-904.
23. Rotter V., Nagaev I., Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003, 278:45777-45784.
24. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K.I., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505.
25. Zhu J., Yong W., Wu X., Yu Y., Lv J., Liu C., et al. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun 2008, 369:471-477.
26. Hsueh H.W., Zhou Z., Allen K.D., Moustaid-Moussa N., Kim J., et al. Stearidonic and eicosapentaenoic acids inhibit interleukin-6 (IL-6) expression in mouse adipose stem cells via toll-like receptor-2 (TLR2) mediated pathway. J Nutr 2011, 141:1260-1266.
27. Le K.A., Mahurkar S., Alderete T.L., Hasson J.S., Adam T.C., Kim T.C., et al. Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway. Diabetes 2011, 60:2802-2809.
28. Saraswathi V., Morrow J.D., Hasty A.H. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice. J Nutr 2009, 139:2380-2386.
29. Kang J.X., Weylandt K.H. Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 2008, 49:133-143.
30. Huber J., Loffler M., Bilban M., Reimers M., Kadl A., Todoric J., et al. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond) 2007, 31:1004-1013.
31. Gabler N.K., Spencer J.D., Webel D.M., Spurlock M.E. n-3 PUFA attenuate lipopolysaccharide-induced down-regulation of toll-like receptor 4 expression in porcine adipose tissue but does not alter the expression of other immune modulators. J Nutr Biochem 2008, 19:8-15.
32. Sampath H., Ntambi J.M. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 2004, 62:333-339.
33. Fernandez-Quintela A., Churruca I., Portillo M.P. The role of dietary fat in adipose tissue metabolism. Public Health Nutr 2007, 10:1126-1131.
34. Wortman P., Miyazaki Y., Kalupahana N.S., Kim S., Hansen-Petrik M., Saxton A.M., et al. n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes. Nutr Metab (Lond) 2009, 6:5.
35. Kalupahana N.S., Claycombe K., Newman S.J., Stewart T., Siriwardhana N., Matthan N., et al. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 2010, 140:1915-1922.
36. Hurt R.T., Frazier T.H., McClave S.A., Kaplan L.M. Obesity epidemic: overview, pathophysiology, and the intensive care unit conundrum. JPEN J Parenter Enteral Nutr 2011, 35:4S-13S.
37. Ailhaud G., Massiera F., Weill P., Legrand P., Alessandri J.M., Guesnet P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 2006, 45:203-236.
38. Hibbeln J.R., Nieminen L.R., Blasbalg T.L., Riggs J.A., Lands W.E. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006, 83:1483S-1493S.
39. Simopoulos A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002, 56:365-379.
40. Kalupahana N.S., Voy B.H., Saxton A.M., Moustaid-Moussa N. Energy-restricted high-fat diets only partially improve markers of systemic and adipose tissue inflammation. Obesity (Silver Spring) 2011, 19:245-254.
41. Wan J.B., Huang L.L., Rong R., Tan R., Wang J., Kang J.X. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arterioscler Thromb Vasc Biol 2010, 30:2487-2494.
42. Mathieu P., Poirier P., Pibarot P., Lemieux I., Despres J.P. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009, 53:577-584.
43. Cassis L.A., Police S.B., Yiannikouris F., Thatcher S.E. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 2008, 10:93-98.
44. Ronti T., Lupattelli G., Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 2006 Apr, 64:355-365.
45. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83:847-850.
46. Harkins J.M., Moustaid-Moussa N., Chung Y.J., Penner K.M., Pestka J.J., North C.M., et al. Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr 2004, 134:2673-2677.
47. Kalupahana N.S., Claycombe K., Moustaid-Moussa N. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic Insights. Adv Nutr 2011, 2:304-316.
48. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003, 100:1751-1756.
49. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.